Multifunctional cell membranes-based nano-carriers for targeted therapies: a review of recent trends and future perspective

References

• Acharya S, Sahoo SK. (2011). PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:1–25. doi: 10.1016/j.addr.2010.10.008.
   PubMed Web of Science ®Google Scholar
• Ahmed SF, Mofijur M, Rafa N, et al. (2022). Green approaches in synthesising nanomaterials for environmental nanobioremediation: technological advancements, applications, benefits and challenges. Environ Res 204:111967. doi: 10.1016/j.envres.2021.111967.
   PubMed Web of Science ®Google Scholar
• Ai X, Wang S, Duan Y, et al. (2020). Emerging approaches to functionalizing cell membrane-coated nanoparticles. Biochemistry 60:941–55. doi: 10.1021/acs.biochem.0c00343.
   PubMed Web of Science ®Google Scholar
• Angsantikul P, Fang RH, Zhang L. (2017). Toxoid vaccination against bacterial infection using cell membrane-coated nanoparticles. Bioconjug Chem 29:604–12. doi: 10.1021/acs.bioconjchem.7b00692.
   PubMed Web of Science ®Google Scholar
• Angsantikul P, Thamphiwatana S, Zhang Q, et al. (2018). Coating nanoparticles with gastric epithelial cell membrane for targeted antibiotic delivery against Helicobacter pylori infection. Adv Ther (Weinh) 1:1800016. doi: 10.1002/adtp.201800016.
   PubMedGoogle Scholar
• Armstrong DK, Bundy B, Wenzel L, et al. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34–43. doi: 10.1056/NEJMoa052985.
   PubMed Web of Science ®Google Scholar
• Aslam B, Wang W, Arshad MI, et al. (2018). Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 11:1645–58. doi: 10.2147/IDR.S173867.
   PubMed Web of Science ®Google Scholar
• Barua S, Mitragotri S. (2013). Synergistic targeting of cell membrane, cytoplasm, and nucleus of cancer cells using rod-shaped nanoparticles. ACS Nano 7:9558–70. doi: 10.1021/nn403913k.
   PubMed Web of Science ®Google Scholar
• Bidkar AP, Sanpui P, Ghosh SS. (2020). Transferrin-conjugated red blood cell membrane-coated poly (lactic-co-glycolic acid) nanoparticles for the delivery of doxorubicin and methylene blue. ACS Appl Nano Mater 3:3807–19. doi: 10.1021/acsanm.0c00502.
   Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33:941–51. doi: 10.1038/nbt.3330.
   PubMed Web of Science ®Google Scholar
• Bose RJ, Kim BJ, Arai Y, et al. (2018). Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia. Biomaterials 185:360–70. doi: 10.1016/j.biomaterials.2018.08.018.
   PubMed Web of Science ®Google Scholar
• Chaplin DD. (2010). Overview of the immune response. J Allergy Clin Immunol 125:S3–S23. doi: 10.1016/j.jaci.2009.12.980.
   PubMed Web of Science ®Google Scholar
• Chen L, Deng H, Cui H, et al. (2018). Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9:7204–18. doi: 10.18632/oncotarget.23208.
   PubMedGoogle Scholar
• Chen M, Chen M, He J. (2019). Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA. Artif Cells Nanomed Biotechnol 47:1635–41. doi: 10.1080/21691401.2019.1608219.
   PubMed Web of Science ®Google Scholar
• Chen M-F, Huang SJ, Huang C-C, et al. (2016). Saikosaponin d induces cell death through caspase-3-dependent, caspase-3-independent and mitochondrial pathways in mammalian hepatic stellate cells. BMC Cancer 16:532. doi: 10.1186/s12885-016-2599-0.
   PubMed Web of Science ®Google Scholar
• Chugh V, Vijaya Krishna K, Pandit A. (2021). Cell membrane-coated mimics: a methodological approach for fabrication, characterization for therapeutic applications, and challenges for clinical translation. ACS Nano 15:17080–123. doi: 10.1021/acsnano.1c03800.
   PubMed Web of Science ®Google Scholar
• Copp JA, Fang RH, Luk BT, et al. (2014). Clearance of pathological antibodies using biomimetic nanoparticles. Proc Natl Acad Sci U S A 111:13481–6. doi: 10.1073/pnas.1412420111.
   PubMed Web of Science ®Google Scholar
• Corbo C, Cromer WE, Molinaro R, et al. (2017). Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases. Nanoscale 9:14581–91. doi: 10.1039/c7nr04734g.
   PubMed Web of Science ®Google Scholar
• Corbo C, Molinaro R, Taraballi F, et al. (2017). Unveiling the in vivo protein corona of circulating leukocyte-like carriers. ACS Nano 11:3262–73. doi: 10.1021/acsnano.7b00376.
   PubMed Web of Science ®Google Scholar
• Crist RM, Grossman JH, Patri AK, et al. (2013). Common pitfalls in nanotechnology: lessons learned from NCI’s Nanotechnology Characterization Laboratory. Integr Biol (Camb) 5:66–73. doi: 10.1039/c2ib20117h.
   PubMed Web of Science ®Google Scholar
• D Friedman, A, SE, Claypool and R. Liu (2013). The smart targeting of nanoparticles. Curr Pharm Des 19:6315–29. doi: 10.2174/13816128113199990375.
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen Z, Shin DM. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–82. doi: 10.1038/nrd2614.
   PubMed Web of Science ®Google Scholar
• De Oliveira S, Rosowski EE, Huttenlocher A. (2016). Neutrophil migration in infection and wound repair: going forward in reverse. Nat Rev Immunol 16:378–91. doi: 10.1038/nri.2016.49.
   PubMed Web of Science ®Google Scholar
• Deirram N, Zhang C, Kermaniyan SS, et al. (2019). pH-responsive polymer nanoparticles for drug delivery. Macromol Rapid Commun 40:e1800917. doi: 10.1002/marc.201800917.
   PubMed Web of Science ®Google Scholar
• Dong X, Chu D, Wang Z. (2017). Leukocyte-mediated delivery of nanotherapeutics in inflammatory and tumor sites. Theranostics 7:751–63. doi: 10.7150/thno.18069.
   PubMed Web of Science ®Google Scholar
• Dong X, Gao J, Zhang CY, et al. (2019). Neutrophil membrane-derived nanovesicles alleviate inflammation to protect mouse brain injury from ischemic stroke. ACS Nano 13:1272–83. doi: 10.1021/acsnano.8b06572.
   PubMed Web of Science ®Google Scholar
• Evangelopoulos M, Yazdi IK, Acciardo S, et al. (2020). Biomimetic cellular vectors for enhancing drug delivery to the lungs. Sci Rep 10:172. doi: 10.1038/s41598-019-55909-x.
   PubMed Web of Science ®Google Scholar
• Fan W, Yung B, Huang P, et al. (2017). Nanotechnology for multimodal synergistic cancer therapy. Chem Rev 117:13566–638. doi: 10.1021/acs.chemrev.7b00258.
   PubMed Web of Science ®Google Scholar
• Fan Z, Zhou H, Li PY, et al. (2014). Structural elucidation of cell membrane-derived nanoparticles using molecular probes. J Mater Chem B 2:8231–8. doi: 10.1039/c4tb00980k.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu C-MJ, Chen KNH, et al. (2013). Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale 5:8884–8. doi: 10.1039/c3nr03064d.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu C-MJ, Luk BT, et al. (2014). Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14:2181–8. doi: 10.1021/nl500618u.
   PubMed Web of Science ®Google Scholar
• Fang RH, Jiang Y, Fang JC, et al. (2017). Cell membrane-derived nanomaterials for biomedical applications. Biomaterials 128:69–83. doi: 10.1016/j.biomaterials.2017.02.041.
   PubMed Web of Science ®Google Scholar
• Fang RH, Kroll AV, Gao W, et al. (2018). Cell membrane coating nanotechnology. Adv Mater 30:1706759. doi: 10.1002/adma.201706759.
   PubMed Web of Science ®Google Scholar
• Fang RH, Zhang L. (2016). Nanoparticle-based modulation of the immune system. Annu Rev Chem Biomol Eng 7:305–26. doi: 10.1146/annurev-chembioeng-080615-034446.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Cheng J, Teply BA, et al. (2006). Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A 103:6315–20. doi: 10.1073/pnas.0601755103.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC. (2012). Using ligands to target cancer cells. Clin Adv Hematol Oncol: H&O 10:543–4.
   PubMedGoogle Scholar
• Fay BL, Melamed JR, Day ES. (2015). Nanoshell-mediated photothermal therapy can enhance chemotherapy in inflammatory breast cancer cells. IJN 10:6931. doi: 10.2147/IJN.S93031.
   Google Scholar
• Feng L, Dou C, Xia Y, et al. (2021). Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery. ACS Nano 15:2263–80. doi: 10.1021/acsnano.0c07973.
   PubMed Web of Science ®Google Scholar
• Gagliardi A, Giuliano E, Venkateswararao E, et al. (2021). Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol 12:601626. doi: 10.3389/fphar.2021.601626.
   PubMed Web of Science ®Google Scholar
• Gao C, Huang Q, Liu C, et al. (2020). Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines. Nat Commun 11:2622. doi: 10.1038/s41467-020-16439-7.
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Jurado-Sánchez B, et al. (2016). Stem cell membrane-coated nanogels for highly efficient in vivo tumor targeted drug delivery. Small 12:4056–62. doi: 10.1002/smll.201600624.
   PubMed Web of Science ®Google Scholar
• Gao C, Lin Z, Wu Z, et al. (2016). Stem-cell-membrane camouflaging on near-infrared photoactivated upconversion nanoarchitectures for in vivo remote-controlled photodynamic therapy. ACS Appl Mater Interfaces 8:34252–60. doi: 10.1021/acsami.6b12865.
   PubMed Web of Science ®Google Scholar
• Gao W, Fang RH, Thamphiwatana S, et al. (2015). Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano Lett 15:1403–9. doi: 10.1021/nl504798g.
   PubMed Web of Science ®Google Scholar
• Gao W, Hu C-MJ, Fang RH, et al. (2013). Liposome-like nanostructures for drug delivery. J Mater Chem B 1:6569–85. doi: 10.1039/C3TB21238F.
   Web of Science ®Google Scholar
• Gao W, Zhang L. (2015). Coating nanoparticles with cell membranes for targeted drug delivery. J Drug Target 23:619–26. doi: 10.3109/1061186X.2015.1052074.
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang L. (2015). Engineering red-blood-cell-membrane–coated nanoparticles for broad biomedical applications. Alche J 61:738–46. doi: 10.1002/aic.14735.
   Web of Science ®Google Scholar
• Gawaz M, Stellos K, Langer H. (2008). Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells. J Thromb Haemost 6:235–42. doi: 10.1111/j.1538-7836.2008.02867.x.
   PubMed Web of Science ®Google Scholar
• Gerritzen MJH, Martens DE, Wijffels RH, et al. (2017). Bioengineering bacterial outer membrane vesicles as vaccine platform. Biotechnol Adv 35:565–74. doi: 10.1016/j.biotechadv.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Greenow K, Pearce NJ, Ramji DP. (2005). The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl) 83:329–42. doi: 10.1007/s00109-004-0631-3.
   PubMed Web of Science ®Google Scholar
• Gunatillake PA, Adhikari R, Gadegaard N. (2003). Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 5:1–16; discussion 16. doi: 10.22203/ecm.v005a01.
   PubMedGoogle Scholar
• Guo Y, Wang D, Song Q, et al. (2015). Erythrocyte membrane-enveloped polymeric nanoparticles as nanovaccine for induction of antitumor immunity against melanoma. ACS Nano 9:6918–33. doi: 10.1021/acsnano.5b01042.
   PubMed Web of Science ®Google Scholar
• Han Y, Pan H, Li W, et al. (2019). T cell membrane mimicking nanoparticles with bioorthogonal targeting and immune recognition for enhanced photothermal therapy. Adv Sci (Weinh) 6:1900251. doi: 10.1002/advs.201900251.
   PubMedGoogle Scholar
• He Y, Li R, Liang J, et al. (2018). Drug targeting through platelet membrane-coated nanoparticles for the treatment of rheumatoid arthritis. Nano Res 11:6086–101. doi: 10.1007/s12274-018-2126-5.
   Web of Science ®Google Scholar
• Holst J, Oster P, Arnold R, et al. (2013). Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother 9:1241–53. doi: 10.4161/hv.24129.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Fang RH, Copp J, et al. (2013). A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol 8:336–40. doi: 10.1038/nnano.2013.54.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Fang RH, Luk BT, et al. (2013). Marker-of-self’functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale 5:2664–8. doi: 10.1039/c3nr00015j.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Fang RH, Wang K-C, et al. (2015). Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526:118–21. doi: 10.1038/nature15373.
   PubMed Web of Science ®Google Scholar
• Hu C-MJ, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A 108:10980–5. doi: 10.1073/pnas.1106634108.
   PubMed Web of Science ®Google Scholar
• Hu Q-Y, Berti F, Adamo R. (2016). Towards the next generation of biomedicines by site-selective conjugation. Chem Soc Rev 45:1691–719. doi: 10.1039/c4cs00388h.
   PubMed Web of Science ®Google Scholar
• Imran M, Shah MR, Ullah F, et al. (2017). Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime. Artif Cells Nanomed Biotechnol 45:1440–51. doi: 10.1080/21691401.2016.1246451.
   PubMed Web of Science ®Google Scholar
• Jeon M, Halbert MV, Stephen ZR, et al. (2021). Iron oxide nanoparticles as T1 contrast agents for magnetic resonance imaging: fundamentals, challenges, applications, and prospectives. Adv Mater 33:1906539. p. doi: 10.1002/adma.201906539.
   Web of Science ®Google Scholar
• Kalidoss M, Yunus Basha R, Doble M, et al. (2019). Theranostic calcium phosphate nanoparticles with potential for multimodal imaging and drug delivery. Front Bioeng Biotechnol 7:126. doi: 10.3389/fbioe.2019.00126.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637–50. doi: 10.1016/j.immuni.2011.05.006.
   PubMed Web of Science ®Google Scholar
• Khoury MK, Yang H, Liu B. (2021). Macrophage biology in cardiovascular diseases. Arterioscler Thromb Vasc Biol 41:e77–e81. doi: 10.1161/ATVBAHA.120.313584.
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. (2013). Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13:159–75. doi: 10.1038/nri3399.
   PubMed Web of Science ®Google Scholar
• Kolhar P, Anselmo AC, Gupta V, et al. (2013). Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. Proc Natl Acad Sci U S A 110:10753–8. doi: 10.1073/pnas.1308345110.
   PubMed Web of Science ®Google Scholar
• Kortel M, Mansuriya BD, Vargas Santana N, et al. (2020). Graphene quantum dots as flourishing nanomaterials for bio-imaging, therapy development, and micro-supercapacitors. Micromachines (Basel) 11:866. doi: 10.3390/mi11090866.
   PubMed Web of Science ®Google Scholar
• Kozlovskaya V, Alexander JF, Wang Y, et al. (2014). Internalization of red blood cell-mimicking hydrogel capsules with pH-triggered shape responses. ACS Nano 8:5725–37. doi: 10.1021/nn500512x.
   PubMed Web of Science ®Google Scholar
• Kroll AV, Fang RH, Jiang Y, et al. (2017). Nanoparticulate delivery of cancer cell membrane elicits multiantigenic antitumor immunity. Adv Mater 29:1703969. doi: 10.1002/adma.201703969.
   Web of Science ®Google Scholar
• Kroll AV, Fang RH, Zhang L. (2017). Biointerfacing and applications of cell membrane-coated nanoparticles. Bioconjug Chem 28:23–32. doi: 10.1021/acs.bioconjchem.6b00569.
   PubMed Web of Science ®Google Scholar
• Kuai Q, Wang Y, Gao F, et al. (2019). Peptide self-assembly nanoparticles loaded with panobinostat to activate latent human immunodeficiency virus. J Biomed Nanotechnol 15:979–92. doi: 10.1166/jbn.2019.2764.
   PubMed Web of Science ®Google Scholar
• Lei C, Qian K, Li T, et al. (2020). Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig. Nat Commun 11:2070. doi: 10.1038/s41467-020-16048-4.
   PubMed Web of Science ®Google Scholar
• Li L-L, Xu J-H, Qi G-B, et al. (2014). Core–shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery. ACS Nano 8:4975–83. doi: 10.1021/nn501040h.
   PubMed Web of Science ®Google Scholar
• Li M, Fang H, Liu Q, et al. (2020). Red blood cell membrane-coated upconversion nanoparticles for pretargeted multimodality imaging of triple-negative breast cancer. Biomater Sci 8:1802–14. doi: 10.1039/d0bm00029a.
   PubMed Web of Science ®Google Scholar
• Li PY, Fan Z, Cheng H. (2018). Cell membrane bioconjugation and membrane-derived nanomaterials for immunotherapy. Bioconjug Chem 29:624–34. doi: 10.1021/acs.bioconjchem.7b00669.
   PubMed Web of Science ®Google Scholar
• Li R, He Y, Zhang S, et al. (2018). Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment. Acta Pharm Sin B 8:14–22. doi: 10.1016/j.apsb.2017.11.009.
   PubMed Web of Science ®Google Scholar
• Li Z, Hu S, Cheng K. (2018). Platelets and their biomimetics for regenerative medicine and cancer therapies. J Mater Chem B 6:7354–65. doi: 10.1039/C8TB02301H.
   PubMed Web of Science ®Google Scholar
• Liang X, Ye X, Wang C, et al. (2019). Photothermal cancer immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Control Release 296:150–61. doi: 10.1016/j.jconrel.2019.01.027.
   PubMed Web of Science ®Google Scholar
• Lim SY, Yuzhalin AE, Gordon-Weeks AN, et al. (2016). Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget 7:28697–710. doi: 10.18632/oncotarget.7376.
   PubMedGoogle Scholar
• Liu C-M, Chen G-B, Chen H-H, et al. (2019). Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Colloids Surf B Biointerfaces 175:477–86. doi: 10.1016/j.colsurfb.2018.12.038.
   PubMed Web of Science ®Google Scholar
• Liu S, Li L, Zhang X, et al. (2023). Nanotherapies from an oncologist doctor’s view. Smart Mater Med 4:183–98. doi: 10.1016/j.smaim.2022.07.005.
   Google Scholar
• Liu X, Yuan L, Zhang L, et al. (2018). Bioinspired artificial nanodecoys for hepatitis B virus. Angewandte Chemie 130:12679–83. doi: 10.1002/ange.201807212.
   Google Scholar
• Liu X-Q, Tang R-Z. (2017). Biological responses to nanomaterials: understanding nano-bio effects on cell behaviors. Drug Deliv 24:1–15. doi: 10.1080/10717544.2017.1375577.
   PubMed Web of Science ®Google Scholar
• Liu Y, Luo J, Chen X, et al. (2019). Cell membrane coating technology: a promising strategy for biomedical applications. Nanomicro Lett 11:100. p. doi: 10.1007/s40820-019-0330-9.
   PubMed Web of Science ®Google Scholar
• Lovitt CJ, Shelper TB, Avery VM. (2018). Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins. BMC Cancer 18:41. doi: 10.1186/s12885-017-3953-6.
   PubMed Web of Science ®Google Scholar
• Luk BT, Hu C-MJ, Fang RH, et al. (2014). Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale 6:2730–7. doi: 10.1039/c3nr06371b.
   PubMed Web of Science ®Google Scholar
• Ma W, Zhu D, Li J, et al. (2020). Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment. Theranostics 10:1281–95. doi: 10.7150/thno.40291.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ma Y, Gao M, et al. (2021). Platelet-mimicking therapeutic system for noninvasive mitigation of the progression of atherosclerotic plaques. Adv Sci (Weinh) 8:2004128. doi: 10.1002/advs.202004128.
   PubMedGoogle Scholar
• Maeda H. (2001). The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-sepective macromolecular drug targeting. Adv Enzyme Regul 41:189–207. doi: 10.1016/s0065-2571(00)00013-3.
   PubMedGoogle Scholar
• Matsumura Y, Maeda H. (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46:6387–92.
   PubMed Web of Science ®Google Scholar
• Melamed JR, Edelstein RS, Day ES. (2015). Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy. ACS Nano 9:6–11. doi: 10.1021/acsnano.5b00021.
   PubMed Web of Science ®Google Scholar
• Mishra P, Jain N. (2003). Folate conjugated doxorubicin-loaded membrane vesicles for improved cancer therapy. Drug Deliv 10:277–82. doi: 10.1080/drd_10_4_277.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter A, Andresen T. (2012). Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol 52:481–503. doi: 10.1146/annurev-pharmtox-010611-134623.
   PubMed Web of Science ®Google Scholar
• Molinaro R, Pastò A, Corbo C, et al. (2019). Macrophage-derived nanovesicles exert intrinsic anti-inflammatory properties and prolong survival in sepsis through a direct interaction with macrophages. Nanoscale 11:13576–86. doi: 10.1039/c9nr04253a.
   PubMed Web of Science ®Google Scholar
• Molinaro R, Pasto A, Taraballi F, et al. (2020). Biomimetic nanoparticles potentiate the anti-inflammatory properties of dexamethasone and reduce the cytokine storm syndrome: an additional weapon against COVID-19? Nanomaterials 10:2301. doi: 10.3390/nano10112301.
   Web of Science ®Google Scholar
• Mu X, Li J, Yan S, et al. (2018). siRNA delivery with stem cell membrane-coated magnetic nanoparticles for imaging-guided photothermal therapy and gene therapy. ACS Biomater Sci Eng 4:3895–905. doi: 10.1021/acsbiomaterials.8b00858.
   PubMed Web of Science ®Google Scholar
• Naahidi S, Jafari M, Edalat F, et al. (2013). Biocompatibility of engineered nanoparticles for drug delivery. J Control Release 166:182–94. doi: 10.1016/j.jconrel.2012.12.013.
   PubMed Web of Science ®Google Scholar
• Narain A, Asawa S, Chhabria V, et al. (2017). Cell membrane coated nanoparticles: next-generation therapeutics. Nanomedicine (Lond) 12:2677–92. doi: 10.2217/nnm-2017-0225.
   PubMed Web of Science ®Google Scholar
• Nel AE, Mädler L, Velegol D, et al. (2009). Understanding biophysicochemical interactions at the nano–bio interface. Nat Mater 8:543–57. doi: 10.1038/nmat2442.
   PubMed Web of Science ®Google Scholar
• Németh T, Sperandio M, Mócsai A. (2020). Neutrophils as emerging therapeutic targets. Nat Rev Drug Discov 19:253–75. doi: 10.1038/s41573-019-0054-z.
   PubMed Web of Science ®Google Scholar
• Nie S. (2010). Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) 5:523–8. doi: 10.2217/nnm.10.23.
   PubMed Web of Science ®Google Scholar
• Oldenborg PA, Zheleznyak A, Fang YF, et al. (2000). Role of CD47 as a marker of self on red blood cells. Science 288:2051–4. doi: 10.1126/science.288.5473.2051.
   PubMed Web of Science ®Google Scholar
• Pan W, Ge Y, Yu Z, et al. (2019). A cancer cell membrane-encapsulated MnO 2 nanoreactor for combined photodynamic-starvation therapy. Chem Commun (Camb) 55:5115–8. doi: 10.1039/c9cc01386e.
   PubMed Web of Science ®Google Scholar
• Parodi A, Molinaro R, Sushnitha M, et al. (2017). Bio-inspired engineering of cell-and virus-like nanoparticles for drug delivery. Biomaterials 147:155–68. doi: 10.1016/j.biomaterials.2017.09.020.
   PubMed Web of Science ®Google Scholar
• Pasto A, Giordano F, Evangelopoulos M, et al. (2019). Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy. Clin Transl Med 8:8–9. p. 1. doi: 10.1186/s40169-019-0224-y.
   PubMed Web of Science ®Google Scholar
• Peer D, et al. (2020). Nanocarriers as an emerging platform for cancer therapy. Nano-Enabled Med Appl 377:1–21.
   Google Scholar
• Perera AS, Coppens M-O. (2019). Re-designing materials for biomedical applications: from biomimicry to nature-inspired chemical engineering. Philos Trans A Math Phys Eng Sci 377:20180268. doi: 10.1098/rsta.2018.0268.
   PubMed Web of Science ®Google Scholar
• Petros RA, DeSimone JM. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9:615–27. doi: 10.1038/nrd2591.
   PubMed Web of Science ®Google Scholar
• Piao J-G, Wang L, Gao F, et al. (2014). Erythrocyte membrane is an alternative coating to polyethylene glycol for prolonging the circulation lifetime of gold nanocages for photothermal therapy. ACS Nano 8:10414–25. doi: 10.1021/nn503779d.
   PubMed Web of Science ®Google Scholar
• Pitchaimani A, Nguyen TDT, Aryal S. (2018). Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy. Biomaterials 160:124–37. doi: 10.1016/j.biomaterials.2018.01.018.
   PubMed Web of Science ®Google Scholar
• Qie Y, Yuan H, von Roemeling CA, et al. (2016). Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes. Sci Rep 6:26269. doi: 10.1038/srep26269.
   PubMed Web of Science ®Google Scholar
• Rao L, Cai B, Bu L-L, et al. (2017). Microfluidic electroporation-facilitated synthesis of erythrocyte membrane-coated magnetic nanoparticles for enhanced imaging-guided cancer therapy. Acs Nano 11:3496–505. doi: 10.1021/acsnano.7b00133.
   PubMed Web of Science ®Google Scholar
• Rao L, Tian R, Chen X. (2020). Cell-membrane-mimicking nanodecoys against infectious diseases. ACS Nano 14:2569–74. doi: 10.1021/acsnano.0c01665.
   PubMed Web of Science ®Google Scholar
• Rao L, Wang W, Meng Q-F, et al. (2018). A biomimetic nanodecoy traps Zika virus to prevent viral infection and fetal microcephaly development. Nano Lett 19:2215–22. doi: 10.1021/acs.nanolett.8b03913.
   PubMed Web of Science ®Google Scholar
• Rao L, Xia S, Xu W, et al. (2020). Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci U S A 117:27141–7. doi: 10.1073/pnas.2014352117.
   PubMed Web of Science ®Google Scholar
• Riley R, O’Sullivan R, Potocny A, et al. (2018). Evaluating nanoshells and a potent biladiene photosensitizer for dual photothermal and photodynamic therapy of triple negative breast cancer cells. Nanomaterials 8:658. doi: 10.3390/nano8090658.
   Web of Science ®Google Scholar
• Riley RS, Day ES. (2017). Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment. Wiley Interdiscip Rev: Nanomed Nanobiotechnol, 9(4):e1449.
   Web of Science ®Google Scholar
• Ruan L, Zhao K, Tian X, et al. (2022). Macrophages exosomes-coated Fe3O4 nanoparticles for oxygen independent generation of free radicals and hypoxic cancer therapy. Mater Today Commun 33:104672. doi: 10.1016/j.mtcomm.2022.104672.
   Web of Science ®Google Scholar
• Safarov T, Kiran B, Bagirova M, et al. (2019). An overview of nanotechnology-based treatment approaches against Helicobacter Pylori. Expert Rev anti Infect Ther 17:829–40. doi: 10.1080/14787210.2019.1677464.
   PubMed Web of Science ®Google Scholar
• Saha T, Bin Mobarak M, Uddin MN, et al. (2023). Biogenic synthesis of copper oxide (CuO) NPs exploiting Averrhoa carambola leaf extract and its potential antibacterial activity. Mater Chem Phys 305:127979. doi: 10.1016/j.matchemphys.2023.127979.
   Web of Science ®Google Scholar
• Sanna V, Pala N, Sechi M. (2014). Targeted therapy using nanotechnology: focus on cancer. Int J Nanomedicine 9:467–83. doi: 10.2147/IJN.S36654.
   PubMed Web of Science ®Google Scholar
• Sargazi S, Laraib U, Er S, et al. (2022). Application of green gold nanoparticles in cancer therapy and diagnosis. Nanomaterials 12:1102. doi: 10.3390/nano12071102.
   Google Scholar
• Schofield ZV, Woodruff TM, Halai R, et al. (2013). Neutrophils—a key component of ischemia-reperfusion injury. Shock 40:463–70. doi: 10.1097/SHK.0000000000000044.
   PubMed Web of Science ®Google Scholar
• Shao J, Abdelghani M, Shen G, et al. (2018). Erythrocyte membrane modified janus polymeric motors for thrombus therapy. ACS Nano 12:4877–85. doi: 10.1021/acsnano.8b01772.
   PubMed Web of Science ®Google Scholar
• She X, Chen L, Yi Z, et al. (2018). Tailored mesoporous silica nanoparticles for controlled drug delivery: platform fabrication, targeted delivery, and computational design and analysis. Mini Rev Med Chem 18:976–89. doi: 10.2174/1389557516666160505114814.
   PubMed Web of Science ®Google Scholar
• Sheng S, Yu X, Xing G, et al. (2023). An apoptotic body-based vehicle with navigation for photothermal-immunotherapy by precise delivery and tumor microenvironment regulation. Adv Funct Mater 33:2212118. doi: 10.1002/adfm.202212118.
   Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, et al. (2017). Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer 17:20–37. doi: 10.1038/nrc.2016.108.
   PubMed Web of Science ®Google Scholar
• Silva AKA, et al. (2013). Cell-derived vesicles as a bioplatform for the encapsulation of theranostic nanomaterials. Nanoscale 5:11374–84.
   PubMed Web of Science ®Google Scholar
• Song Y, Huang Z, Liu X, et al. (2019). Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice. Nanomedicine 15:13–24. doi: 10.1016/j.nano.2018.08.002.
   PubMed Web of Science ®Google Scholar
• Sparano JA, Wang M, Martino S, et al. (2008). Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358:1663–71. doi: 10.1056/NEJMoa0707056.
   PubMed Web of Science ®Google Scholar
• Su Y, Wang T, Su Y, et al. (2020). A neutrophil membrane-functionalized black phosphorus riding inflammatory signal for positive feedback and multimode cancer therapy. Mater Horiz 7:574–85. doi: 10.1039/C9MH01068H.
   Web of Science ®Google Scholar
• Suck G, Odendahl M, Nowakowska P, et al. (2016). NK-92: an ‘off-the-shelf therapeutic’for adoptive natural killer cell-based cancer immunotherapy. Cancer Immunol Immunother 65:485–92. doi: 10.1007/s00262-015-1761-x.
   PubMed Web of Science ®Google Scholar
• Suk JS, Xu Q, Kim N, et al. (2016). PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99:28–51. doi: 10.1016/j.addr.2015.09.012.
   PubMed Web of Science ®Google Scholar
• Sun D, Chen J, Wang Y, et al. (2019). Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery. Theranostics 9:6885–900. doi: 10.7150/thno.36510.
   PubMed Web of Science ®Google Scholar
• Sun H, Su J, Meng Q, et al. (2016). Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors. Adv Mater 28:9581–8. doi: 10.1002/adma.201602173.
   PubMed Web of Science ®Google Scholar
• Sun H, Su J, Meng Q, et al. (2017). Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer. Adv Funct Mater 27:1604300. doi: 10.1002/adfm.201604300.
   Web of Science ®Google Scholar
• Sun K, Yu W, Ji B, et al. (2020). Saikosaponin D loaded macrophage membrane-biomimetic nanoparticles target angiogenic signaling for breast cancer therapy. Appl Mater Today 18:100505. doi: 10.1016/j.apmt.2019.100505.
   Web of Science ®Google Scholar
• Sushnitha M, Evangelopoulos M, Tasciotti E, et al. (2020). Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications. Front Bioeng Biotechnol 8:627. doi: 10.3389/fbioe.2020.00627.
   PubMed Web of Science ®Google Scholar
• Tang C, Wang C, Zhang Y, et al. (2019). Recognition, intervention, and monitoring of neutrophils in acute ischemic stroke. Nano Lett 19:4470–7. doi: 10.1021/acs.nanolett.9b01282.
   PubMed Web of Science ®Google Scholar
• Thamphiwatana S, Angsantikul P, Escajadillo T, et al. (2017). Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management. Proc Natl Acad Sci U S A 114:11488–93. doi: 10.1073/pnas.1714267114.
   PubMed Web of Science ®Google Scholar
• Thon JN, Italiano JE. (2012). Platelets: production, morphology and ultrastructure. Antiplatelet Agents 27:1–7.
   Google Scholar
• Tian H, Luo Z, Liu L, et al. (2017). Cancer cell membrane-biomimetic oxygen nanocarrier for breaking hypoxia-induced chemoresistance. Adv Funct Mater 27:1703197. doi: 10.1002/adfm.201703197.
   Web of Science ®Google Scholar
• Tietjen GT, Bracaglia LG, Saltzman WM, et al. (2018). Focus on fundamentals: achieving effective nanoparticle targeting. Trends Mol Med 24:598–606. doi: 10.1016/j.molmed.2018.05.003.
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726–36. doi: 10.1038/nri2395.
   PubMed Web of Science ®Google Scholar
• Valcourt DM, Dang MN, Day ES. (2019). IR820-loaded PLGA nanoparticles for photothermal therapy of triple-negative breast cancer. J Biomed Mater Res A 107:1702–12. doi: 10.1002/jbm.a.36685.
   PubMed Web of Science ®Google Scholar
• Valencia PM, Hanewich-Hollatz MH, Gao W, et al. (2011). Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. Biomaterials 32:6226–33. doi: 10.1016/j.biomaterials.2011.04.078.
   PubMed Web of Science ®Google Scholar
• Veiseh O, Gunn JW, Zhang M. (2010). Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 62:284–304. doi: 10.1016/j.addr.2009.11.002.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Langer R, Farokhzad OC. (2012). Nanoparticle delivery of cancer drugs. Annu Rev Med 63:185–98. doi: 10.1146/annurev-med-040210-162544.
   PubMed Web of Science ®Google Scholar
• Wang C, Wang S, Chen Y, et al. (2021). Membrane nanoparticles derived from ACE2-rich cells block SARS-CoV-2 infection. ACS Nano 15:6340–51. doi: 10.1021/acsnano.0c06836.
   PubMed Web of Science ®Google Scholar
• Wang D, Dong H, Li M, et al. (2018). Erythrocyte–cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano 12:5241–52. doi: 10.1021/acsnano.7b08355.
   PubMed Web of Science ®Google Scholar
• Wang F, Gao W, Thamphiwatana S, et al. (2015). Hydrogel retaining toxin-absorbing nanosponges for local treatment of methicillin-Resistant Staphylococcus aureus infection. Adv Mater 27:3437–43. doi: 10.1002/adma.201501071.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu J, Williams GR, et al. (2019). Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery. J Nanobiotechnol 17:60. p. doi: 10.1186/s12951-019-0494-y.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang R, Meng N, et al. (2020). Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy. J Control Release 328:78–86. doi: 10.1016/j.jconrel.2020.08.030.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang K, Li T, et al. (2021). Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Theranostics 11:164–80. doi: 10.7150/thno.47841.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang K, Qin X, et al. (2019). Biomimetic nanotherapies: red blood cell based core–shell structured nanocomplexes for atherosclerosis management. Adv Sci (Weinh) 6:1900172. doi: 10.1002/advs.201900172.
   PubMedGoogle Scholar
• Wei X, Gao J, Fang RH, et al. (2016). Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials 111:116–23. doi: 10.1016/j.biomaterials.2016.10.003.
   PubMed Web of Science ®Google Scholar
• Wei X, Gao J, Wang F, et al. (2017). In situ capture of bacterial toxins for antivirulence vaccination. Adv Mater 29:1701644. doi: 10.1002/adma.201701644.
   Web of Science ®Google Scholar
• Wei X, Zhang G, Ran D, et al. (2018). T-cell-mimicking nanoparticles can neutralize HIV infectivity. Adv Mater 30:1802233. doi: 10.1002/adma.201802233.
   PubMed Web of Science ®Google Scholar
• Wright HL, Cox T, Moots RJ, et al. (2017). Neutrophil biomarkers predict response to therapy with tumor necrosis factor inhibitors in rheumatoid arthritis. J Leukoc Biol 101:785–95. doi: 10.1189/jlb.5A0616-258R.
   PubMed Web of Science ®Google Scholar
• Wypij M, Jędrzejewski T, Trzcińska-Wencel J, et al. (2021). Green synthesized silver nanoparticles: antibacterial and anticancer activities, biocompatibility, and analyses of surface-attached proteins. Front Microbiol 12:632505. doi: 10.3389/fmicb.2021.632505.
   PubMed Web of Science ®Google Scholar
• Xia Q, Zhang Y, Li Z, et al. (2019). Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application. Acta Pharm Sin B 9:675–89. doi: 10.1016/j.apsb.2019.01.011.
   PubMed Web of Science ®Google Scholar
• Xie W, Deng W-W, Zan M, et al. (2019). Cancer cell membrane camouflaged nanoparticles to realize starvation therapy together with checkpoint blockades for enhancing cancer therapy. ACS Nano 13:2849–57. doi: 10.1021/acsnano.8b03788.
   PubMed Web of Science ®Google Scholar
• Xu L, Wu S, Wang J. (2019). Cancer cell membrane–coated nanocarriers for homologous target inhibiting the growth of hepatocellular carcinoma. J Bioact Compat Polym 34:58–71. doi: 10.1177/0883911518819107.
   Web of Science ®Google Scholar
• Xuan M, Shao J, Dai L, et al. (2016). Macrophage cell membrane camouflaged Au nanoshells for in vivo prolonged circulation life and enhanced cancer photothermal therapy. ACS Appl Mater Interfaces 8:9610–8. doi: 10.1021/acsami.6b00853.
   PubMed Web of Science ®Google Scholar
• Xue Y, Zeng G, Cheng J, et al. (2021). Engineered macrophage membrane-enveloped nanomedicine for ameliorating myocardial infarction in a mouse model. Bioeng Transl Med 6:e10197. doi: 10.1002/btm2.10197.
   PubMed Web of Science ®Google Scholar
• Yang Q, Lai SK. (2015). Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev: Nanomed Nanobiotechnol 7:655–77.
   PubMed Web of Science ®Google Scholar
• Ye X, Liang X, Chen Q, et al. (2019). Surgical tumor-derived personalized photothermal vaccine formulation for cancer immunotherapy. ACS Nano 13:2956–68. doi: 10.1021/acsnano.8b07371.
   PubMed Web of Science ®Google Scholar
• Yi Y, Yu M, Li W, et al. (2023). Vaccine-like nanomedicine for cancer immunotherapy. J Control Release 355:760–78. doi: 10.1016/j.jconrel.2023.02.015.
   PubMed Web of Science ®Google Scholar
• Yoo J-W, Chambers E, Mitragotri S. (2010). Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr Pharm Des 16:2298–307. doi: 10.2174/138161210791920496.
   PubMed Web of Science ®Google Scholar
• Yu K, Chen Y, Zhang L, et al. (2023). Cancer-erythrocyte membrane-mimicking Fe3O4 nanoparticles and DHJS for ferroptosis/immunotherapy synergism in tumors. ACS Appl Mater Interfaces 15:44689–710. doi: 10.1021/acsami.3c07379.
   PubMed Web of Science ®Google Scholar
• Yu X, Trase I, Ren M, et al. (2016). Design of nanoparticle-based carriers for targeted drug delivery. J Nanomater 2016:1–15. doi: 10.1155/2016/1087250.
   Web of Science ®Google Scholar
• Yu X, Xing G, Sheng S, et al. (2023). Neutrophil camouflaged stealth nanovehicle for photothermal-induced tumor immunotherapy by triggering pyroptosis. Adv Sci 10:2207456. doi: 10.1002/advs.202207456.
   Web of Science ®Google Scholar
• Yu Y, Cheng Q, Ji X, et al. (2022). Engineered drug-loaded cellular membrane nanovesicles for efficient treatment of postsurgical cancer recurrence and metastasis. Sci Adv 8:eadd3599. doi: 10.1126/sciadv.add3599.
   PubMed Web of Science ®Google Scholar
• Yuk SA, Kim H, Abutaleb NS, et al. (2021). Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis. Sci Adv 7:eabj1577. doi: 10.1126/sciadv.abj1577.
   PubMed Web of Science ®Google Scholar
• Zhang C, Ma Y, Zhang J, et al. (2022). Modification of lipid-based nanoparticles: an efficient delivery system for nucleic acid-based immunotherapy. Molecules 27:1943. doi: 10.3390/molecules27061943.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang P-Q, Guo S, et al. (2020). Application of biomimetic cell-derived nanoparticles with mannose modification as a novel vaccine delivery platform against teleost fish viral disease. ACS Biomater Sci Eng 6:6770–7. doi: 10.1021/acsbiomaterials.0c01302.
   PubMed Web of Science ®Google Scholar
• Zhang G, Campbell GR, Zhang Q, et al. (2020). CD4+ t cell-mimicking nanoparticles broadly neutralize hiv-1 and suppress viral replication through autophagy. MBio 11:e00903-20. doi: 10.1128/mBio.00903-20.
   PubMed Web of Science ®Google Scholar
• Zhang J, Gao W, Fang RH, et al. (2015). Synthesis of nanogels via cell membrane-templated polymerization. Small 11:4309–13. doi: 10.1002/smll.201500987.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li R, Chen H, et al. (2017). Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles combined with low-dose irradiation: a new approach to enhance drug targeting in gastric cancer. Int J Nanomed 12:2129–42. doi: 10.2147/IJN.S126016.
   PubMed Web of Science ®Google Scholar
• Zhang N, Li M, Sun X, et al. (2018). NIR-responsive cancer cytomembrane-cloaked carrier-free nanosystems for highly efficient and self-targeted tumor drug delivery. Biomaterials 159:25–36. doi: 10.1016/j.biomaterials.2018.01.007.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Dehaini D, Zhang Y, et al. (2018). Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis. Nat Nanotechnol 13:1182–90. doi: 10.1038/s41565-018-0254-4.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Honko A, Zhou J, et al. (2020). Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett 20:5570–4. doi: 10.1021/acs.nanolett.0c02278.
   PubMed Web of Science ®Google Scholar
• Zhang X, He S, Ding B, et al. (2020). Cancer cell membrane-coated rare earth doped nanoparticles for tumor surgery navigation in NIR-II imaging window. Chem Eng J 385:123959. doi: 10.1016/j.cej.2019.123959.
   Web of Science ®Google Scholar
• Zhang Y, Sun Y, Dong X, et al. (2022). A platelet intelligent vehicle with navigation for cancer photothermal-chemotherapy. ACS Nano 16:6359–71. doi: 10.1021/acsnano.2c00453.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Chen W, et al. (2017). Erythrocyte membrane-coated nanogel for combinatorial antivirulence and responsive antimicrobial delivery against Staphylococcus aureus infection. J Controlled Release 263:185–91. doi: 10.1016/j.jconrel.2017.01.016.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xie R, Yodsanit N, et al. (2021). Hydrogen peroxide-responsive platelet membrane-coated nanoparticles for thrombus therapy. Biomater Sci 9:2696–708. doi: 10.1039/d0bm02125c.
   PubMed Web of Science ®Google Scholar
• Zhou H, Fan Z, Lemons PK, et al. (2016). A facile approach to functionalize cell membrane-coated nanoparticles. Theranostics 6:1012–22. doi: 10.7150/thno.15095.
   PubMed Web of Science ®Google Scholar
• Zhu D-M, Xie W, Xiao Y-S, et al. (2018). Erythrocyte membrane-coated gold nanocages for targeted photothermal and chemical cancer therapy. Nanotechnology 29:084002. doi: 10.1088/1361-6528/aa9ca1.
   PubMed Web of Science ®Google Scholar
• Zhu J-Y, Zheng D-W, Zhang M-K, et al. (2016). Preferential cancer cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic cancer cell membranes. Nano Lett 16:5895–901. doi: 10.1021/acs.nanolett.6b02786.
   PubMed Web of Science ®Google Scholar
• Zhu Y-D, Chen S-P, Zhao H, et al. (2016). PPy@ MIL-100 nanoparticles as a pH-and near-IR-irradiation-responsive drug carrier for simultaneous photothermal therapy and chemotherapy of cancer cells. ACS Appl Mater Interfaces 8:34209–17. doi: 10.1021/acsami.6b11378.
   PubMed Web of Science ®Google Scholar
• Zolnik BS, González-Fernández A, Sadrieh N, et al. (2010). Minireview: nanoparticles and the immune system. Endocrinology 151:458–65. doi: 10.1210/en.2009-1082.
   PubMed Web of Science ®Google Scholar